Sharon E. Tetlow's most recent trade in Structure Therapeutics Inc - ADR was a trade of 51,804 Share Option (right to buy) done . Disclosure was reported to the exchange on June 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc... | Sharon E. Tetlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 51,804 | 51,804 | - | - | Share Option (right to buy) | |
| Structure Therapeutics Inc... | Sharon E. Tetlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 37,500 | 37,500 | - | - | Share Option (right to buy) | |
| Crescent Biopharma Inc. | Sharon E. Tetlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) |